Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

EPA/ABNX stock hub

EPA/ABNX has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

EPA/ABNXis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

125.1M

Euronext Paris

Market data

Price

Recent price action with selectable time range.

EPA/ABNXEPA/ABNX

—

Loading chart…

In the news

Latest news · EPA/ABNX

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC-176.2

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All EPA/ABNX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

133

Groups with data

Currency

EUR

Showing 133 of 133 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	France
Country code	FR
Employees	51
Employees Change	-10%
Employees Change Percent	-16.39
Enterprise value	EUR 125.8M
Exchange	Euronext Paris
Financial currency	EUR
First seen	2026-05-10
Industry	Biotechnology
Isin	FR0012616852
Last refreshed	2026-05-10
Market cap	EUR 125.1M
Price	EUR 3.55
Price currency	EUR
Rev Per Employee	80,392.16x
Sector	Healthcare
Sic	2836
Symbol	epa/ABNX
Website	https://abionyx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-4.4%
EV Earnings	-22.87x
EV/Sales	30.68x
P/S ratio	30.5x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-134.15%
EBITDA Margin	-131.1%
Gross margin	14.63%
Gross Profit	EUR 600,000
Gross Profit Growth	-21.98%
Gross Profit Growth Q	-31.24%
Gross Profit Growth3 Y	-13.65%
Gross Profit Growth5 Y	2.4%
Net Income	EUR -5.5M
Net Income Growth Years	0%
Pretax Margin	-134.15%
Profit Margin	-134.15%
Profit Per Employee	EUR -107,843
ROIC	-176.2
Roic5y	-110.2

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-8.57%
Cagr1y	190.79%
Cagr3y	25.86%
Cagr5y	26.79%
EPS Growth Years	0
Revenue Growth	-9.91x
Revenue Growth Q	-10.24x
Revenue Growth Years	0x
Revenue Growth3 Y	-5.48x
Revenue Growth5 Y	-2.9x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Interest Coverage	-27.5
WACC	7.44

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-59.16%
1Y total return	190.57%
200-day SMA	3.45
3Y total return	99.38%
50-day SMA	3.47
50-day SMA vs 200-day SMA	50over200
5Y total return	227.63%
All Time High	14.44
All Time High Change	-75.45%
All Time High Date	2015-06-01
All Time Low	0.2
All Time Low Change	1,672.5%
All Time Low Date	2019-10-25
ATR	0.16
Beta	0.58
Beta1y	-0.49
Beta2y	-0.14
Ch YTD	-6.34
High	3.65
High52	5.29
High52 Date	2025-10-28
High52ch	-32.99%
Low	3.52
Low52	1.17
Low52 Date	2025-06-30
Low52ch	202.99%
Ma50ch	2.16%
Price vs 200-day SMA	2.63%
RSI	49.27
RSI Monthly	65.65
RSI Weekly	51.85
Sharpe ratio	1.61x
Sortino ratio	3.34
Tr YTD	-6.34
Tr1m	2.16%
Tr1w	3.96%
Tr3m	-3.27%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -5.5M
Operating margin	-134.1

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	19,865,674%
Shares Insiders	35.79%
Shares Institutions	4.3%
Shares Out	35,278,030

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	83,501.85x
Ch10y	-59.16
Ch1m	2.16
Ch1w	3.96
Ch1y	190.6
Ch3m	-3.27
Ch3y	99.38
Ch5y	227.6
Ch6m	-16.19
Change	-1.53%
Change From Open	-1.53
Close	3.6
Days Gap	0
Depreciation Amortization	125,000
Dollar Volume	133,341.6
Earnings Date	2026-09-24
EBIT	EUR -5.5M
EBITDA	EUR -5.4M
F Score	1
Financing CF	3,400,000
Fiscal Year End	December
Founded	2,005
Investing CF	-200,000
Is Primary Listing	1
Last Earnings Date	2026-03-12
Last Report Date	2025-12-31
Ma150	3.68
Ma150ch	-3.56%
Ma20	3.63
Ma20ch	-2.23%
Net CF	300,000
Next Earnings Date	2026-09-24
Open	3.6
Position In Range	19.23
Price Date	2026-05-08
Relative Volume	0.44x
Revenue	4,100,000x
Tr6m	-16.19%
Volume	37,614

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does EPA/ABNX pay a dividend?

Capital-return profile for this ticker.

Performance

EPA/ABNX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns EPA/ABNX?

Insider, institutional, and short-interest positioning.

Institutional ownership

+4.3%

Share of float held by funds and institutions

Insider ownership

+35.8%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

EPA/ABNX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

49.3

Neutral momentum band

Price vs 200-day MA

+2.6%

50/200-day relationship not available

Beta (5Y)

0.58

Less volatile than the market

Sharpe ratio

1.61

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About EPA/ABNX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current epa/ABNX stock rating?

epa/ABNX is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full epa/ABNX analysis?

The full report lives at /stocks/epa/ABNX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for epa/ABNX?

The latest report frames epa/ABNX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the epa/ABNX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.